Tina L Morhardt, Atsushi Hayashi, John Y Kao, Nobuhiko Kamada
{"title":"Regional control of regulatory immune cells in the intestine.","authors":"Tina L Morhardt, Atsushi Hayashi, John Y Kao, Nobuhiko Kamada","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The intestine contains the largest compartment of immune regulatory cells which include T regulatory cells and IL-10 producing macrophages. These cell populations serve to restrain unnecessary immune responses of the intestine, which may lead to the pathogenesis of Crohn's disease or food allergy.</p><p><strong>Recent findings: </strong>This review discusses the recent findings pertaining to the functional regulation of these cells which may provide insight into novel therapies. Both T regulatory cells and macrophages are regulated in microbiota-dependent and microbiota-independent manners, i.e., dietary antigens. Often, this is specific to regional specialization and environment in small intestine vs. colon.</p><p><strong>Summary: </strong>These immune regulatory cells are largely regulated by microbiota in the colon, whereas in the small intestine, the microbiota has less affect, as seen in germ-free mice studies. Targeting these cells in their specific compartments may direct future treatment modalities for inflammatory bowel disease as ulcerative colitis and Crohn's are vastly different diseases.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"6 1","pages":"29-34"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943041/pdf/nihms934729.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pathobiology Reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: The intestine contains the largest compartment of immune regulatory cells which include T regulatory cells and IL-10 producing macrophages. These cell populations serve to restrain unnecessary immune responses of the intestine, which may lead to the pathogenesis of Crohn's disease or food allergy.
Recent findings: This review discusses the recent findings pertaining to the functional regulation of these cells which may provide insight into novel therapies. Both T regulatory cells and macrophages are regulated in microbiota-dependent and microbiota-independent manners, i.e., dietary antigens. Often, this is specific to regional specialization and environment in small intestine vs. colon.
Summary: These immune regulatory cells are largely regulated by microbiota in the colon, whereas in the small intestine, the microbiota has less affect, as seen in germ-free mice studies. Targeting these cells in their specific compartments may direct future treatment modalities for inflammatory bowel disease as ulcerative colitis and Crohn's are vastly different diseases.
期刊介绍:
This journal aims to offer expert review articles on the most important recent research pertaining to biological mechanisms underlying disease, including etiology, pathogenesis, and the clinical manifestations of cellular alteration. By providing clear, insightful, balanced contributions, the journal intends to serve those for whom the elucidation of new techniques and technologies related to pathobiology is essential. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include autophagy, cancer stem cells, induced pluripotential stem cells (iPS cells), inflammation and cancer, matrix pathobiology, miRNA in pathobiology, mitochondrial dysfunction/diseases, and myofibroblast.